Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Myeloid 1

Conditions

Ulcer 1Tomaculous neuropathy 1Thrombocythemia, Essential 1Stomatitis 1Stomach Neoplasms 1Radiation Pneumonitis 1Primary Myelofibrosis 1Polycythemia Vera 1Polycystic Ovary Syndrome 1Neuroma 1Myeloproliferative Disorders 1Median Neuropathy 1Lung Neoplasms 1Lung Diseases, Interstitial 1Hand Injuries 1Disease 1Carpal Tunnel Syndrome 1Breast Neoplasms 1

Interventions

ruxolitinib 4Specimen Handling 2Biopsy 211-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 2talazoparib 1poly ICLC 1piperine 1fludarabine phosphate 1fludarabine 1fedratinib 1demethoxycurcumin 1bomedemstat 1X-Rays 1Whole-Body Irradiation 1Watchful Waiting 1Tacrolimus 1Stem Cell Transplantation 1Positron-Emission Tomography 1N(4)-oleylcytosine arabinoside 1Mycophenolic Acid 1Methotrexate 1Melphalan 1Injections 1Hematopoietic Stem Cell Transplantation 1Decitabine 1Cyclophosphamide 1Curcumin 1Aspirin 1Acetylcysteine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Thrombocythemia, Essential × Acetylcysteine × Clear all
NCT05123365 2026-03-10

An Optimal Dose Finding Study of N-Acetylcysteine in Patients With Myeloproliferative Neoplasms

University of California, Irvine

Phase 1/2 Recruiting
27 enrolled
Myeloid

Myeloproliferative Disorders, Polycythemia Vera, Thrombocythemia, Essential, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡